
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+7
OXB (LSE: OXB) is a quality and innovation-led contract development and manufacturing organisation (CDMO) in cell and gene therapy with a mission to enable its clients to deliver life changing therapies to patients around the world. One of the original pioneers in cell and gene therapy, the Company has more than 25 years of experience in viral vectors; the driving force behind the majority of gene therapies. The Company collaborates with some of the worlds most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, adeno-associated virus (AAV) and adenoviral vectors. Oxford Biomedicas world-class capabilities...
Gene therapy,immunotherapy,viral vector gmp manufacturing,cell and gene therapy,lentiviral vectors,aav, cell therapy,cdmo,gmp,process development,manufacturing,and advanced therapies
Oxford biomedica operates in the Pharmaceutical manufacturing industry.
Oxford biomedica's HQ phone number is +44 207 1347329
Oxford biomedica's revenue is 11m - 100m
Oxford biomedica has 501 - 1000 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.